Windlas Biotech Ltd. IPO Details
If you Open Your Demat account with Us You will
Get Free Membership of Premium Telegram Channel.
Let’s have a detailed review of the company and analytics of the Windlas Biotech IPO release date, IPO offer price, subscription, Windlas Biotech Limited IPO allotment, Windlas Biotech grey market premium, and other details like the company’s background, financial positions of Windlas Biotech Ipo, its promoters, and other related things.
About Windlas Biotech Ltd. Company :-
Windlas Biotech Limited, Incorporated in 2001 is one of the top 5 leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India in terms of revenue. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics. Company also sell its own branded products in the trade generics and OTC markets as well as export generic products
to several countries.
Currently, the focus of the company is to launch complex generic products in the chronic therapeutic category related to lifestyle-related disorders. Our complex generic products portfolio primarily comprises fixed dosage
combinations, fixed dosage plus modified release combinations, customized generics and chewable or dispersible,
which was 68.48% in Fiscal 2021 of our total
product portfolio.
The business operates in 3 verticals;
1. CDMO Products and services,
2. Domestic trade generics and Over-the-counter (OTC) market, and
3. Export.
We currently own and operate four manufacturing facilities located at Dehradun in Uttarakhand.
Company have developed relationships with various leading Indian pharmaceutical companies, including
Pfizer Limited, Sanofi India Limited, Cadila Healthcare Limited/ Zydus Healthcare Limited, Emcure
Pharmaceuticals Limited, Eris Lifesciences Limited, Intas Pharmaceuticals Limited and Systopic Laboratories
Private Limited.
In Fiscal 2020, we provided CDMO services to seven of the top 10 Indian formulations
pharmaceutical companies
Promoters Of Windlas Biotech Ltd. :-
The Promoters of Company are Ashok Kumar Windlass, Hitesh Windlass, Manoj Kumar Windlass, and AKW WBL Family Pvt. Trust.
Promoter Holdings :-
| Pre Issue Promoter Holdings | 78% |
|---|---|
| Post Issue Promoter Holdings | 65.16% |
Financials Of Windlas Biotech Ltd. :-
| Particulars | Financials | {Figs. in Millions} | ||
|---|---|---|---|---|
| 31 March 2019 | 31 March 2020 | 31 March 2021 | ||
| Total Assets | 2,981.80 | 3,384.88 | 2,961.23 | |
| Total Revenue | 3,115.25 | 3,313.39 | 4,306.95 | |
| Total Expenses | 2,841.88 | 2,992.05 | 3,871.65 | |
| Profit After Tax | 638.22 | 162.13 | 155.70 | |
| EPS | 38.61 | 8.90 | 8.70 |
Financials Ratios :-
PE Ratio - 52.8
Sector PE -
Peers of Windlas Biotech Ltd. :-
As per Company RHP,
There are no listed companies in India that engage in a business similar to that of our Company. Hence, it is
not possible to provide an industry comparison in relation to our Company.
Windlas Biotech Ltd. Ipo Details :-
| IPO Opening Date | 4 Aug, 2021 |
|---|---|
| IPO Closing Date | 6 Aug, 2021 |
| Face Value | ₹5 per equity share |
| IPO Price | ₹448 to ₹460 per equity share |
| Min. Order Quantity | 30 Shares |
| Issue Size | ₹401.54 Cr |
| Fresh Issue | ₹165 Cr |
| Offer for Sale | ₹236.54 Cr |
| Listing At | BSE NSE |
Shares Offered to :-
QIB 50% NII 15% RII 35%
Objectives Of Ipo :-
The net proceeds from the IPO will be utilized towards the following purposes.
- To Repay of company's borrowings fully or partially.
- To purchase equipment required for capacity expansion of our existing facility at Dehradun Plant IV and addition of injectables dosage capability at our existing facility at Dehradun Plant-II;
- To finance incremental working capital requirements of the company.
- General corporate purposes.
Ipo Timeline :-
| Ipo Dates | 4 - 6 August 21 |
| Allotment Date | 11 August 21 |
| Initiation of Refunds | 12 August 21 |
| Credit of Share to Demat Account | 13 August 21 |
| Ipo Listing Date | 17 August 21 |
Windlas Biotech Ipo Grey Market Premium :-
On 4 August 2021 - Rs.
On 3 August 2021 - Rs. 130
On 2 August 2021 - Rs. 150
On 1 August 2021 - Rs. 150
Windlas Biotech Ltd. IPO Registrar :-
Link Intime India Private Ltd.

Comments
Post a Comment